glp-1 agonists cancer risk 📌 Most viewed this week from JAMA Oncology: Glucagon-like peptide-1 receptor (#GLP1s) are associated with a reduced overall #cancer in adults with #obesity, lowering the risk for endometrial, ovarian, and Quantity:Double-Pack ($69) goal:glp-1-support GLP-1 Support Patch Pack

glp-1 agonists cancer risk 📌 Most viewed this week from JAMA Oncology: Glucagon-like peptide-1 receptor (#GLP1s) are associated with a reduced overall #cancer in adults with #obesity, lowering the risk for endometrial, ovarian, and Quantity:Double-Pack ($69) goal:glp-1-support GLP-1 Support Patch Pack

GLP-1 Support Patch Pack

In mouse models of NASH, GLP-/GIP dual agonists have also been found to significantly reduce TG and LDL-C and increase high-density lipoprotein cholesterol (HDL-C) [127]

goal:glp-1-support

Quantity:Double-Pack ($69)

Therefore, delayed gastric emptying might be attenuated with long- or prolonged-acting GLP-1 analogs compared to short-acting GLP-1 analogs